Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.04
RAD's Cash to Debt is ranked lower than
53% of the 610 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.57 vs. RAD: 0.04 )
RAD' s 10-Year Cash to Debt Range
Min: 0   Max: 0.13
Current: 0.04

0
0.13
Equity to Asset -0.25
RAD's Equity to Asset is ranked lower than
54% of the 590 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.43 vs. RAD: -0.25 )
RAD' s 10-Year Equity to Asset Range
Min: -0.38   Max: 0.41
Current: -0.25

-0.38
0.41
Interest Coverage 1.70
RAD's Interest Coverage is ranked lower than
54% of the 437 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 15.24 vs. RAD: 1.70 )
RAD' s 10-Year Interest Coverage Range
Min: 0.02   Max: 4.75
Current: 1.7

0.02
4.75
F-Score: 7
Z-Score: 3.46
M-Score: -2.50
WACC vs ROIC
33.59%
105.30%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) 3.29
RAD's Operating margin (%) is ranked higher than
76% of the 613 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.42 vs. RAD: 3.29 )
RAD' s 10-Year Operating margin (%) Range
Min: -8.84   Max: 6.03
Current: 3.29

-8.84
6.03
Net-margin (%) 7.95
RAD's Net-margin (%) is ranked higher than
95% of the 613 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.00 vs. RAD: 7.95 )
RAD' s 10-Year Net-margin (%) Range
Min: -11.09   Max: 7.37
Current: 7.95

-11.09
7.37
ROA (%) 28.58
RAD's ROA (%) is ranked higher than
100% of the 614 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.09 vs. RAD: 28.58 )
RAD' s 10-Year ROA (%) Range
Min: -29.43   Max: 19.7
Current: 28.58

-29.43
19.7
ROC (Joel Greenblatt) (%) 23.53
RAD's ROC (Joel Greenblatt) (%) is ranked higher than
83% of the 613 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 18.27 vs. RAD: 23.53 )
RAD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -42.94   Max: 23.78
Current: 23.53

-42.94
23.78
Revenue Growth (3Y)(%) -3.00
RAD's Revenue Growth (3Y)(%) is ranked higher than
54% of the 511 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.20 vs. RAD: -3.00 )
RAD' s 10-Year Revenue Growth (3Y)(%) Range
Min: -16   Max: 15.1
Current: -3

-16
15.1
EBITDA Growth (3Y)(%) 24.50
RAD's EBITDA Growth (3Y)(%) is ranked higher than
95% of the 473 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.80 vs. RAD: 24.50 )
RAD' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -84.3   Max: 24.5
Current: 24.5

-84.3
24.5
» RAD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

RAD Guru Trades in Q1 2014

George Soros 2,043,700 sh (New)
Jim Simons 1,593,000 sh (New)
Paul Tudor Jones 2,104,420 sh (+2212.55%)
Ray Dalio 1,085,900 sh (+720.17%)
Ken Fisher 12,100 sh (+5.22%)
Pioneer Investments Sold Out
Jeremy Grantham Sold Out
John Burbank 26,509 sh (-14.94%)
John Hussman 1,000,000 sh (-16.67%)
David Einhorn 5,511,246 sh (-54.53%)
Steven Cohen 1,126,005 sh (-76.41%)
Joel Greenblatt 158,445 sh (-83.80%)
» More
Q2 2014

RAD Guru Trades in Q2 2014

Pioneer Investments 15,803 sh (New)
Andreas Halvorsen 13,458,963 sh (New)
Joel Greenblatt 3,163,882 sh (+1896.83%)
Jim Simons 5,364,888 sh (+236.78%)
George Soros 2,300,000 sh (+12.54%)
John Hussman 1,000,000 sh (unchged)
David Einhorn Sold Out
Ken Fisher 10,350 sh (-14.46%)
John Burbank 10,922 sh (-58.80%)
Ray Dalio 233,800 sh (-78.47%)
Paul Tudor Jones 54,449 sh (-97.41%)
» More
Q3 2014

RAD Guru Trades in Q3 2014

Steven Cohen 3,364,900 sh (New)
Ray Dalio 2,124,000 sh (+808.47%)
Joel Greenblatt 12,788,466 sh (+304.20%)
John Burbank 39,265 sh (+259.50%)
Ken Fisher 10,350 sh (unchged)
Jim Simons Sold Out
Andreas Halvorsen Sold Out
George Soros Sold Out
Paul Tudor Jones 54,400 sh (-0.09%)
John Hussman 500,000 sh (-50.00%)
» More
Q4 2014

RAD Guru Trades in Q4 2014

NWQ Managers 206,300 sh (New)
Louis Moore Bacon 1,150,000 sh (New)
Paul Tudor Jones 108,474 sh (+99.40%)
Ray Dalio 2,487,194 sh (+17.10%)
Ken Fisher 10,850 sh (+4.83%)
John Burbank Sold Out
John Hussman Sold Out
Joel Greenblatt 3,434,880 sh (-73.14%)
Steven Cohen 79,200 sh (-97.65%)
» More
» Details

Insider Trades

Latest Guru Trades with RAD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Rite Aid Corp

Joel Greenblatt: the Value Investment Magician's Most Recent Buys
Joel Greenblatt (Trades, Portfolio), founder of Gotham Asset Management, is a true value investor. He truly stands behind Warren Buffett (Trades, Portfolio)’s philosophy for buying stocks, which is to buy cheap stocks belonging to a good company. In order to figure out just how good a company is, Greenblatt looks at returns on tangible capital to fulfill his ultimate goal of finding something both cheap and good. Read more...
Weekly Insider Sells Highlight: RAD, KOS, SNDK, AFOP
According to GuruFocus Insider Data, the largest insider sells during the past week were: Rite Aid Corp., Kosmos Energy Ltd., SanDisk Corp., Crown Holdings Inc. and Alliance Fiber Optic Products Inc. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 24.70
RAD's P/E(ttm) is ranked higher than
72% of the 680 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 27.60 vs. RAD: 24.70 )
RAD' s 10-Year P/E(ttm) Range
Min: 3.17   Max: 6590
Current: 24.7

3.17
6590
Forward P/E 28.74
RAD's Forward P/E is ranked higher than
62% of the 680 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 26.11 vs. RAD: 28.74 )
N/A
PE(NRI) 26.30
RAD's PE(NRI) is ranked higher than
75% of the 680 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 28.00 vs. RAD: 26.30 )
RAD' s 10-Year PE(NRI) Range
Min: 3.18   Max: 219
Current: 26.3

3.18
219
P/B 133.40
RAD's P/B is ranked lower than
61% of the 680 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.79 vs. RAD: 133.40 )
RAD' s 10-Year P/B Range
Min: 0.29   Max: 139.2
Current: 133.4

0.29
139.2
P/S 0.31
RAD's P/S is ranked higher than
78% of the 680 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.60 vs. RAD: 0.31 )
RAD' s 10-Year P/S Range
Min: 0.01   Max: 0.34
Current: 0.31

0.01
0.34
PFCF 50.00
RAD's PFCF is ranked higher than
67% of the 680 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 75.00 vs. RAD: 50.00 )
RAD' s 10-Year PFCF Range
Min: 1.88   Max: 80.83
Current: 50

1.88
80.83
POCF 12.92
RAD's POCF is ranked higher than
76% of the 680 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.40 vs. RAD: 12.92 )
RAD' s 10-Year POCF Range
Min: 0.54   Max: 67
Current: 12.92

0.54
67
EV-to-EBIT 18.54
RAD's EV-to-EBIT is ranked higher than
75% of the 680 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 18.66 vs. RAD: 18.54 )
RAD' s 10-Year EV-to-EBIT Range
Min: -477   Max: 618
Current: 18.54

-477
618
Current Ratio 1.77
RAD's Current Ratio is ranked higher than
86% of the 592 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.14 vs. RAD: 1.77 )
RAD' s 10-Year Current Ratio Range
Min: 0.81   Max: 3.28
Current: 1.77

0.81
3.28
Quick Ratio 0.55
RAD's Quick Ratio is ranked higher than
64% of the 592 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.66 vs. RAD: 0.55 )
RAD' s 10-Year Quick Ratio Range
Min: 0.13   Max: 0.78
Current: 0.55

0.13
0.78
Days Inventory 56.74
RAD's Days Inventory is ranked higher than
65% of the 680 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 41.65 vs. RAD: 56.74 )
RAD' s 10-Year Days Inventory Range
Min: 59.45   Max: 129.21
Current: 56.74

59.45
129.21
Days Sales Outstanding 13.50
RAD's Days Sales Outstanding is ranked higher than
79% of the 680 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 21.48 vs. RAD: 13.50 )
RAD' s 10-Year Days Sales Outstanding Range
Min: 4.16   Max: 19.41
Current: 13.5

4.16
19.41

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 3.10
RAD's Price/Median PS Value is ranked lower than
54% of the 680 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.30 vs. RAD: 3.10 )
RAD' s 10-Year Price/Median PS Value Range
Min: 0.09   Max: 9.14
Current: 3.1

0.09
9.14
Price/Peter Lynch Fair Value 1.40
RAD's Price/Peter Lynch Fair Value is ranked higher than
95% of the 680 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.00 vs. RAD: 1.40 )
RAD' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.16   Max: 29.82
Current: 1.4

0.16
29.82
Earnings Yield (Greenblatt) 5.50
RAD's Earnings Yield (Greenblatt) is ranked higher than
69% of the 609 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.90 vs. RAD: 5.50 )
RAD' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.2   Max: 10.3
Current: 5.5

0.2
10.3
Forward Rate of Return (Yacktman) 20.44
RAD's Forward Rate of Return (Yacktman) is ranked higher than
89% of the 447 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 7.93 vs. RAD: 20.44 )
RAD' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -36.6   Max: 36.3
Current: 20.44

-36.6
36.3

Analyst Estimate

Feb16 Feb17 Feb18
Revenue(Mil) 28,547 30,784 35,104
EPS($) 0.28 0.38 0.50
EPS without NRI($) 0.28 0.38 0.50

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers
Compare:SHDMF, APNHF, GNC, JCOUF, PMC » details
Traded in other countries:RTA.Germany,
Rite Aid Corp a Delaware corporation was incorporated on 1968. It operates retail drugstore chain in the United States. It operates its drugstores in 31 states across the country and in the District of Columbia. As of March 3, 2012, it operated 4,587 stores. The Company sells prescription drugs and an assortment of other merchandise, which it calls 'front end' products. Front end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other convenience products. The Company attempts to distinguish its stores from other national chain drugstores, in part, through its wellness + loyalty program, private brands and its strategic alliance with GNC, a retailer of vitamin and mineral supplements. The retail drugstore industry is competitive. It competes with retail drugstore chains, independently owned drugstores, supermarkets, mass merchandisers, discount stores, wellness offerings, dollar stores and mail order pharmacies. The Company's business is subject to federal, state, and local government laws, regulations and administrative practices.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK